duces severe side effects and is no longer efficacious, Xenografts of porcine dopaminergic neurons were also successfully grafted in animal models, but the risk of oxygen tension or to the absence of appropriate survival factors, only 1%-10% of the grafted cells (100-1000 interspecies viral infection may prohibit their usage in the clinic (Galpern et al., 1996) . Finally, attempts are dopaminergic neurons) survived more than a few days. Compared to the substantia nigra of a normal rat, which being made to recapitulate the ontogeny of dopaminergic neurons (Hynes et al., 1995) and to produce them contains ‫000,03ف‬ dopaminergic neurons, the number of stably grafted neurons was quite low. Nevertheless, in large amounts in a test tube. However, these studies are in the early experimental phases. Now, in this issue it was sufficient to restore some of the motor deficits in the rodent Parkinsonian model and to justify clinical of Neuron, Dr. Ló pez-Barneo and colleagues (Espejo et al., 1998) describe another source of cells for transtrials in human.
Human clinical trials using dopaminergic neurons plantation, the glomus cells of the carotid bodies. The carotid bodies in human are 5 mm long nodules from aborted human fetuses were conducted in the late 1980s (Lindvall et al., 1988; Madrazo et al., 1988) . These located near the carotid sinus. They are estimated to be composed of at least 100,000 epithelial "glomus" trials revealed a dramatic improvement in motor function, a decreased dependence on L-DOPA, and an in-(type I) cells and 4,000-8,000 support or sheath (type II) cells (J. Ló pez-Barneo, personal communication), crease in the levels of striatal dopamine in some patients. Other patients, however, showed no benefits and and their function is to monitor changes in blood levels of O 2 , CO 2 , and H ϩ brought about by physiological continued to decline. As in the animal models, the variability among human transplant recipients was subsestressors such as hypoxia, high altitude, and exercise. Changes in blood gases, detected by the carotid bodies, quently shown to result from the poor survival rate of the transplanted cells. The amount of dopamine proare then reported to the medulla through the carotid sinus nerve, a component of the IX cranial nerve, and duced by the few surviving neurons was often not sufficient to ameliorate the motor deficits. As a consequence lead to an alteration in breathing that allows adequate gas exchange to meet the body's metabolic demands of these findings the number of transplanted cells was significantly increased. Today, up to 500,000 midbrain (Berger and Hornbein, 1989) . Interestingly, the glomus cells, whose embryonic origin is the neural crest, have precursors, containing ‫000,03ف‬ dopaminergic neurons (equivalent to the number of dopaminergic neurons in some neuronal-like characters and are rich in dopamine. Whereas neurons will degenerate and die at the low the entire rat substantia nigra) are being used in the rodent Parkinson's model (with the aid of antioxidants, oxygen tensions characteristic of the transplant environment, glomus cells thrive in hypoxic conditions, producthe percentage of surviving cells has been increased to 20% or 6000 dopaminergic neurons; A. Bjö rklund, ing and secreting even greater amounts of dopamine.
To test the efficacy of glomus cell grafts in a model of personal communication). Likewise, it is now acceptable to use cells from up to 10 human fetuses for a Parkinson's disease, Ló pez-Barneo's group transplanted them into one side of the rat substantia nigra, which single graft into a Parkinson's patient. Although this increase in cell number has led to a more consistent had been destroyed by injection of the neurotoxin 6-Hydroxydopamine (Schwarting and Huston, 1996) . and favorable clinical outcome, it nonetheless renders this type of transplantation therapy impractical as a rouPrior to transplantation, these rats had a reduction of Ͼ90% in the number of dopaminergic neurons in the tine treatment. The Carotid Body lesioned side, and a similar decrease in the amount of dopamine in the ipsilateral striatum. These rats exhibited Given the potential benefit of transplantation, alternative sources of cells that can provide dopamine are consignificant abnormalities in motor function including: (1) spontaneous rotation toward the lesioned side that was stantly being explored ( Figure 1 , Table 2 ). For example, adrenal medulla cells were tested in animal models and accentuated following treatment with amphetamine (amphetamine promotes flux reversal by plasma memin humans (Yurek and Sladek, 1990) . However, only 1/1000 of these cells survived the striatal environment brane monamine transporters, thereby releasing dopamine); (2) a 50% decrease in free locomotion that may for more than a few days. Moreover, although adrenal medulla cells make dopamine, they do not secrete it reflect an inability to initiate movement (akinesia); (3) an increased response time in the whisker touch test, a efficiently and therefore their therapeutic benefit is poor. reversing akinesia not demonstrated may produce survival factors; induce rapid recovery in an animal model measure of sensorimotor orientation; and (4) asymmetry finding that 400 glomus cells could improve sensorimotor tests may again indicate that they make and secrete in the direction of movement along the cage wall, a measure of sensorimotor neglect. more dopamine than dopaminergic neurons and are therefore more efficient in rescuing motor deficits. AlterOf the 400-600 glomus cells that were grafted (rats have 2,000-3,000 glomus cells per carotid body), over natively, differences in the experimental paradigms may be responsible for the apparent discrepancies. Side-by-60% survived for the entire duration of the experiments, which is a significantly better survival rate than for adreside comparison of these two cell types will have to be conducted to resolve this issue. nal medulla cells or fetal dopaminergic neurons. Moreover, three months following the transplantation, some Lesioned animals that received the glomus cell grafts did not improve in the test of distance traveled in an of the glomus cells extended through the host tissue fibers with varicose presynaptic-like structures, allowing open field, indicating that their ability to initiate and execute movements is still impaired. Reversal of this regulated and widespread release of dopamine.
The second piece of good news is that the lesioned symptom, however, may require transplantation into the nucleus accumbens, a distinct innervation target of animals showed a rapid recovery from biochemical and motor deficits. Dopamine levels in the transplanted side dopaminergic neurons, which lies outside of the basal ganglia. Ló pez-Barneo and colleagues did not yet atincreased from 11% to 65% of the contralateral striatum; the animals no longer exhibited significant spontaneous, tempt this. An additional benefit of the carotid body grafts lies or amphetamine-induced rotation; and their scores improved in two of the three sensorimotor tests.
in their potential ability to induce arborization of the endogenous dopaminergic terminals. Such sprouting of The significant increase in striatal dopamine following transplantation of only 400-600 glomus cells is surpristhe resident dopaminergic neurons, which is not observed with transplants of fetal neurons, may suggest ing given the fact that the rat striatum is normally innervated by ‫000,03ف‬ dopaminergic neurons. This finding that the carotid cells secrete, in addition to dopamine, a survival or a sprouting factor for dopaminergic neumay suggest that glomus cells produce a lot more dopamine than the endogenous dopaminergic neurons (comrons. A survival factor could greatly enhance the therapeutic potential of carotid body cells since it may be parison of reported dopamine contents in glomus cells and dopaminergic neurons from different species indeed able to protect endogenous dopaminergic neurons from further degeneration. In fact, part of the observed imsuggest that glomus cells may contain 3-to 45-fold more dopamine; J. Ló pez-Barneo, personal communication).
provement in the sensorimotor test could be attributed to sprouting of the endogenous dopaminergic neurons. Alternatively, since the neurons responsible for dopamine re-uptake have been lesioned, the high levels of Although the carotid bodies are necessary for adequate ventilation in response to low oxygen, removal dopamine may reflect its accumulation in the extracellular environment rather than an elevated production caof one carotid body is not detrimental. Thus, another advantage of the carotid bodies is that they could in pacity of the glomus cells. Additional measurements of dopamine content in glomus cells and dopaminergic principle be used for autotransplantation, providing a ready source of cells and eliminating the need for imneurons in a single species will have to be performed in order to distinguish between these two possibilities.
mune suppression, which is now used as a precautionary measure with the fetal grafts. The improvement in two sensorimotor tests is also quite unexpected given the low number of transplanted 415-440. able to do the same job? Second, beneficial effect on the more debilitating and difficult-to-reverse symptoms of Parkinson's disease, akinesia and postural balance, will have to be demonstrated. Finally, more information on the ability of glomus cells to secrete neurotrophic factors, and on the possible beneficial effects of the neuropeptides (e.g., enkephalins, VIP) and neurotransmitters (e.g., acetylcholine) that these cells produce, will have to be gathered. Even if a single carotid body is not a sufficient cell source, the relative ease of purifying glomus cells and their abundance in the carotid body may allow the generation of useful glomus cell lines for grafting purposes. In addition, studies on the mechanisms that support the survival of glomus cells in the striatum may eventually help in improving the survival rate of transplanted primary dopaminergic neurons.
Carotid body transplants have been tried before but with less success (Bing et al., 1988) . The difference appears to lie in the way the grafts were prepared in the two studies. Whereas previous investigators use dispersed cells, Ló pez-Barneo and his colleagues used cell aggregates, which probably allow better recovery and the retention of the glomus cell phenotype.
For lack of an adequate cell source, transplantation has not been a widely adopted therapeutic approach. Although it is not the ideal therapy for Parkinson's disease, it does provide significant benefits. The glomus cell grafts, which appear to provide an enriched source of dopamine-producing cells that survive well, may change this situation.
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